Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial. Gogenur I, Justesen TF, Tarpgaard LS, Bulut M, et al. Ann Surg 2024 Dec 18. doi: 10.1097/SLA.0000000000006611.

Read + Share

Amedeo Smart

Independent Medical Education

Gogenur I, Justesen TF, Tarpgaard LS, Bulut M, et al. Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial. Ann Surg 2024 Dec 18. doi: 10.1097/SLA.0000000000006611.
PMID: 39692004